10/30/2020  11:50:28 AM Chg. +0.40 Volume Bid11:50:32 AM Ask11:50:43 AM Market Capitalization Dividend Y. P/E Ratio
86.30EUR +0.47% 13,341
Turnover: 1.15 mill.
86.25Bid Size: 331 86.35Ask Size: 192 2.7 bill.EUR 1.40% 33.42

Business description

Gerresheimer is a leading global partner to the pharma and healthcare industry. With its specialty glass and plastic products, the company contributes to health and well-being. It has worldwide operations and about 10,000 employees manufacture the products in local markets, close to its customers. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.
 

Management board & Supervisory board

CEO
Dietmar Siemssen
Management board
Dr. Bernd Metzner, Dr. Lukas Burkhardt
Supervisory board
Dr. Axel Herberg, Francesco Grioli, Andrea Abt, Dr. Karin Louise Dorrepaal, Dr. Peter Noé, Franz Hartinger, Heike Arndt, Katja Schnitzler, Markus Rocholz, Paul Schilling, Theodor Stuth, Udo J. Vetter
 

Company data

Name: Gerresheimer AG
Address: Klaus-Bungert-Straße 4,D-40468 Düsseldorf
Phone: +49-211-6181-00
Fax: +49-211-6181-295
E-mail: info@gerresheimer.com
Internet: www.gerresheimer.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 11/30
Free Float: 57.30%
IPO date: 6/11/2007

Investor relations

Name: Carolin Nadilo
IR phone: +49-211-6181-314
IR Fax: +49-211-6181-121
IR e-mail: carolin.nadilo@gerre...mer.com carolin.nadilo@gerresheimer.com

Company calendar

CW 8 | 2/16/2021 4th Quarter/Annual Report
CW 15 | 4/8/2021 Interim Report 1st Quarter/3 Months
CW 24 | 6/9/2021 General Shareholder Meeting
CW 29 | 7/13/2021 Interim Report 2nd Quarter/6 Months
CW 42 | 10/12/2021 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
57.30%
NN Group N.V.
 
10.05%
AllianceBernstein Corporation
 
4.87%
Schroders plc
 
4.82%
Neuberger Berman Investment Advisers LLC
 
3.06%
BlackRock Inc.
 
3.00%
Ameriprise Financial, Inc.
 
3.00%
Fidelity Funds SICAV
 
3.00%
Templeton Investment Counsel, LLC
 
2.98%
Others
 
7.92%